Savara price target lowered to $9 from $10 at JMP Securities
PremiumThe FlySavara price target lowered to $9 from $10 at JMP Securities
3M ago
Savara reports Q2 EPS (12c), consensus (11c)
Premium
The Fly
Savara reports Q2 EPS (12c), consensus (11c)
3M ago
Largest borrow rate increases among liquid names
Premium
The Fly
Largest borrow rate increases among liquid names
4M ago
Savara price target raised to $15 from $11 at Oppenheimer
PremiumThe FlySavara price target raised to $15 from $11 at Oppenheimer
5M ago
Jefferies sees 50%-100% stock move possible after Savara Phase 3 success
Premium
The Fly
Jefferies sees 50%-100% stock move possible after Savara Phase 3 success
5M ago
Savara’s IMPALA-2 Trial Success and FDA Submission Plan
Premium
Company Announcements
Savara’s IMPALA-2 Trial Success and FDA Submission Plan
5M ago
Savara reports Q1 EPS (11c), consensus (10c)
PremiumThe FlySavara reports Q1 EPS (11c), consensus (10c)
6M ago
Savara management to meet with Oppenheimer
Premium
The Fly
Savara management to meet with Oppenheimer
6M ago
Savara management to meet with Oppenheimer
Premium
The Fly
Savara management to meet with Oppenheimer
6M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100